Skip to main content

'Mad Money' Lightning Round: Xilinx, Keysight Technologies

Jim Cramer’s bullish on Xilinx and Keysight Technologies, but says Amarin is only for speculation.
  • Author:
  • Publish date:

Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Wednesday evening:

Keysight Technologies  (KEYS) - Get Keysight Technologies Inc. Report: "I really like this one. It should be higher."

Amarin  (AMRN) - Get Amarin Corporation plc Report: "This is speculative and should only be bought as a spec."

Paysafe PSFE: "I believe in this company. With shares down 10%, I'm a buyer."

Xilinx  (XLNX) - Get Xilinx Inc. Report: "I can't wait for the acquisition to close. I like it."

Humanigen  (HGEN) - Get Humanigen Inc. Report: "You want Regeneron Pharmaceuticals  (REGN) - Get Regeneron Pharmaceuticals Inc. Report."

TransMedics Group  (TMDX) - Get TransMedics Group Inc. Report: "This is a very hard problem to solve and I don't think it's going to be a profitable business anytime soon."

Scroll to Continue

TheStreet Recommends

Read the full Mad Money Recap from Monday's show, Cramer's Mad Money Recap: Coinbase, Gamestop. Cramer interviewed

Cramer and the AAP team are looking at everything from earnings and politics to the Federal Reserve. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.

On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had no position in the stocks mentioned.